Goal and Learning Outcomes

The goal of this smoking cessation educational program is to help respiratory therapists, pharmacists, dietitians/nutritionists, nurses, occupational therapists, and social workers work together to create a successful plan to help patients quit smoking. After taking this course, you should be able to:
  • Identify the stages of behavior change that patients experience during the process of smoking cessation.
  • Describe three smoking cessation approaches or aids that healthcare providers can suggest to patients.
  • Identify interprofessional healthcare team members and their roles in smoking cessation.
  • Describe key considerations with the seven FDA-approved smoking cessation medications available.
  • Differentiate between potential benefits of electronic cigarettes in aiding smoking cessation and possible safety concerns.

Course Authors

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.